Literature DB >> 20858822

Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.

Satoshi Goshima1, Masayuki Kanematsu, Haruo Watanabe, Hiroshi Kondo, Yoshimune Shiratori, Minoru Onozuka, Noriyuki Moriyama.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the gadoxetate disodium-enhanced MRI findings of hepatic hemangioma and to investigate the diagnostic performance in differentiating hepatic hemangioma and metastasis.
MATERIALS AND METHODS: Images of 32 hepatic hemangiomas in 25 patients and of 29 hepatic metastatic lesions in 20 patients were retrospectively reviewed. Two independent readers interpreted hepatobiliary phase images alone, dynamic extracellular phase images alone, and combined hepatobiliary and dynamic extracellular phase images. MRI findings and performance with respect to the differential diagnosis of hemangioma and metastasis were assessed.
RESULTS: During the hepatic arterial phase, 11 of the 32 hemangiomas (34%) exhibited early total enhancement, and nine (28%) exhibited peripheral nodular enhancement. A bright dot sign or minimal peripheral enhancement during the late dynamic phase was observed for a small number of lesions (6% and 28%, respectively). Twenty-three of the 29 metastatic lesions (79%) exhibited ring enhancement during the hepatic arterial phase. Twenty-nine hemangiomas (91%) and all of the metastatic lesions exhibited homogeneous or heterogeneous hypointensity during the hepatobiliary phase. The sensitivity, specificity, and area under the receiver operating characteristic curve for the detection of hemangioma were 76%, 81%, and 0.87 for the hepatobiliary phase alone; 97%, 88%, and 0.97 for the dynamic extracellular phase alone; and 97%, 88%, and 0.98 for the combination. Five nodules smaller than 1 cm (four hemangiomas, one metastatic lesion) that exhibited no enhancement during the arterial phase and minimal enhancement during the late dynamic phase were not differentiated.
CONCLUSION: Gadoxetate disodium-enhanced MRI was found useful for differentiating hepatic hemangiomas and metastatic lesions, especially during the dynamic extracellular phase. Only a limited number of lesions smaller than 1 cm in diameter, which exhibited minimal enhancement on late dynamic phase images, were difficult to diagnose.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858822     DOI: 10.2214/AJR.09.3730

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

Review 2.  Solid liver masses: approach to management from the standpoint of a radiologist.

Authors:  Robert Garrett
Journal:  Curr Gastroenterol Rep       Date:  2013-12

3.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

4.  Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Takamichi Murakami; Shunsuke Onoe; Hiroyuki Tokue; Kentaro Shibamoto; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

5.  Characterization of pediatric liver lesions with gadoxetate disodium.

Authors:  Arthur B Meyers; Alexander J Towbin; Suraj Serai; James I Geller; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2011-06-24

6.  Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Hiroyuki Tokue; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2011-07-12       Impact factor: 5.315

Review 7.  [Benign focal hepatic lesions].

Authors:  S Baroud; N Bastati; H Prosch; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

8.  Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.

Authors:  Govind B Chavhan; Erika Mann; Binita M Kamath; Paul S Babyn
Journal:  Pediatr Radiol       Date:  2014-04-27

9.  Evaluation of Transient Motion During Gadoxetic Acid-Enhanced Multiphasic Liver Magnetic Resonance Imaging Using Free-Breathing Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Mi Hye Yu; Bo Yun Hur; Robert Grimm; Kai Tobias Block; Hersh Chandarana; Berthold Kiefer; Yohan Son
Journal:  Invest Radiol       Date:  2018-01       Impact factor: 6.016

10.  Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.

Authors:  Peter Bannas; Candice A Bookwalter; Tim Ziemlewicz; Utaroh Motosugi; Alejandro Munoz Del Rio; Theodora A Potretzke; Scott K Nagle; Scott B Reeder
Journal:  Eur Radiol       Date:  2016-04-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.